Search Results
Jun 10, 2026, 09:25 ET Matter Bio Announces FDA Clearance of IND Application for LM-LLO-TT in Pancreatic Ductal Adenocarcinoma
FDA clearance enables initiation of first-in-human Phase 1/2a clinical trial evaluating LM-LLO-TT, Matter Bio's attenuated Listeria monocytogenes-based immunotherapy candidate.SAN FRANCISCO, June
More news about: Matter Bio
Jun 10, 2026, 03:54 ET GIGABYTE verbessert die Motherboard-Leistung mit KI-gestützten Technologien
Mit dem zunehmenden Einsatz von KI-Anwendungen verbindet GIGABYTE KI-gestützte Leistungsoptimierung, Hardwaredesign und BIOS-Optimierung zu einer intelligenteren und flexibleren Motherboard-Plattform. X3D Turbo Mode 2.0 ist darauf ausgelegt, AMD Ryzen™ X3D-Prozessoren auf
More news about: GIGABYTE
Jun 09, 2026, 22:23 ET GIGABYTE présente ses performances CQDIMM exceptionnelles et le développement de son écosystème au salon COMPUTEX 2026
circuit de la carte mère et un réglage avancé du système d'entrée-sortie de base (BIOS). La conception perfectionnée du circuit réduit la charge des canaux de mémoire et améliore l'intégrité des signaux, tandis que le réglage du BIOS gère intelligemment le timing, la synchronisation des signaux et le comportement
More news about: GIGABYTE
Jun 09, 2026, 22:01 ET GIGABYTE EVENT dévoile un ensemble complet de nouveaux produits avec « ENTER INFINITY » au COMPUTEX 2026
qui permet d'obtenir des performances optimales avec une capacité de 256 Go dans les configurations Dual-DIMM, tandis que la technologie de réglage du BIOS D5 DUO X gère intelligemment le timing, la synchronisation des signaux et le comportement de la tension sans compromis entre la capacité et la vitesse.
More news about: GIGABYTE
Jun 09, 2026, 21:33 ET 技嘉「ENTER INFINITY」發表會登場，揭曉 COMPUTEX 2026 新品陣容
組裝體驗除 INFINITY 系列外，技嘉亦持續推進效能提升與 PC 美學設計。全新 Z890 Plus 系列採用創新的 CQDIMM 技術 ，以雙 DIMM 架構提供極致的記憶體效能、更優異的訊號完整性，實現 256GB 高容量與高速表現，結合獨家的 D5 DUO X BIOS 調校技術，透過最佳化的時脈驅動架構，智慧管理時序、訊號同步與電壓，進一步釋放 Z890 平台的完整效能。兼具效能與產品設計美學的 AERO WOOD 系列從主機板延伸至顯示卡產品線，首次推出 AORUS GeForce RTX™ 5080 INFINITY WOOD 顯示卡，進一步將自然材質美學應用至高效能硬體。Project
More news about: GIGABYTE
Jun 09, 2026, 09:39 ET Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
of BLKR201. This swift progression is an important step in evaluating the clinical potential of our discovery and underscores the power of Formation Bio's accelerated development model. We look forward to their continued progress as they advance this promising asset, expand the therapeutic opportunities,
More news about: Lynk Pharmaceuticals Co., Ltd.
Jun 09, 2026, 09:00 ET Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor
being developed through Formation Bio's subsidiary Bleecker Bio. "Through our hub-and-spoke model, every asset benefits both from the power of our core in-house development expertise as well as the dedicated attention of a focused team, plugged into Formation Bio's AI ecosystem at every point of development.
More news about: Formation Bio
Jun 09, 2026, 09:00 ET AccessLex Institute® Announces New Thought Leadership Blog
include:Featured articles for high-impact issues;A searchable database with easy-to-use filters;Author bios highlighting subject matter experts; andLarge repository of articles and expertise.Content spans a range of perspectives,
More news about: AccessLex Institute
Jun 09, 2026, 09:00 ET Providence Swedish Neuroscience Institute (PSNI) Reaches Milestone in Reducing Global Burden of Glioblastoma
approaches are urgently needed," says Steve Reed, Ph.D., founder and CEO of HDT Bio. "We are encouraged by these early findings and pleased that HDT Bio's technology is contributing to a collaborative effort to address this devastating disease."The first stage of the five-year project concluded
More news about: Providence
Jun 09, 2026, 08:34 ET Immorta Bio Discusses its AI-Enabled Personalized Therapeutic Paradigm for Restoring Youthful Biology at Leading Global Biotech Forum
longevity and regenerative medicine, where restoring youthful biology increasingly requires highly personalized therapeutic approaches.Immorta Bio's first-in-class therapeutic paradigm is centered on restoring youthful biology through the simultaneous targeting of two fundamental drivers of aging:
More news about: Immorta Bio Inc.
Jun 09, 2026, 08:23 ET First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
the originators of this promising molecule and a new investor in Windward Bio, we strongly believe in the potential of HBM9378/WIN378 and Windward Bio's execution capabilities. We look forward to supporting the continued advancement of the program and ultimately bringing innovative treatment options
More news about: Harbour BioMed
Jun 09, 2026, 08:00 ET Matica Biotechnology announces engagement by University Health Network (UHN) to supply cGMP Manufacturing of IL-10 Adenoviral Therapy for Lung Transplantation
inflammation and enhance graft function, potentially increasing the availability and success of lung transplants.This collaboration highlights Matica Bio's growing role as a trusted CDMO partner for viral vector programs across gene therapy, immuno-oncology, and regenerative medicine, offering end-to-end
More news about: Matica Biotechnology, Inc.
Jun 09, 2026, 01:29 ET A GIGABYTE aprimora o desempenho das placas-mãe com tecnologias baseadas em IA
toda a placa-mãe para melhorar a integridade do sinal e manter o desempenho máximo em layouts multicamadas. Além disso, o HyperTune BIOS, a tecnologia de otimização de BIOS baseada em IA da GIGABYTE, ajusta de forma inteligente o comportamento da memória para alcançar um aumento significativo na frequência
More news about: GIGABYTE
Jun 08, 2026, 04:36 ET GIGABYTE perfecciona el rendimiento de las placas base con tecnologías basadas en IA
placa base para mejorar la integridad de la señal y mantener un rendimiento máximo en los diseños multicapa. Además, HyperTune BIOS, la tecnología de optimización de la BIOS basada en IA de GIGABYTE, ajusta de forma inteligente el comportamiento de la memoria para lograr una velocidad de reloj notablemente
More news about: GIGABYTE
Jun 07, 2026, 23:00 ET 技嘉以創新 AI 驅動技術樹立主機板效能新標竿
隨著 AI 技術快速發展，技嘉進一步整合 AI 驅動效能調校、硬體設計與 BIOS 韌體優化，打造更智慧、高效能且更具適應性的運算平台。其中，X3D Turbo Mode 2.0 為技嘉 AI 關鍵技術的核心之一，專為 AMD Ryzen™ X3D 處理器打造，並結合 AI 動態超頻模型與內建板載晶片，一鍵即可提升系統效能。透過大數據訓練的 AI 動態超頻模型，針對每顆處理器進行最佳化調校；板載晶片則可即時監控系統運作狀態與工作負載，透過軟硬體整合，帶來更智慧、快速且最佳化的效能設定，滿足遊戲、創作與高負載運算需求。技嘉也透過 AI
More news about: GIGABYTE
Jun 07, 2026, 23:00 ET GIGABYTE Advances Motherboard Performance with AI-driven Technologies
the motherboard to enhance signal integrity and maintain peak performance across multi-layer motherboard layouts. In addition, HyperTune BIOS, GIGABYTE's AI-driven BIOS optimization technology, intelligently fine-tunes memory behavior to achieve significant memory clock speed and enhanced overall system
More news about: GIGABYTE
Jun 07, 2026, 23:00 ET GIGABYTE Advances Motherboard Performance with AI-driven Technologies
the motherboard to enhance signal integrity and maintain peak performance across multi-layer motherboard layouts. In addition, HyperTune BIOS, GIGABYTE's AI-driven BIOS optimization technology, intelligently fine-tunes memory behavior to achieve significant memory clock speed and enhanced overall system
More news about: GIGABYTE
Jun 07, 2026, 23:00 ET GIGABYTE améliore les performances des cartes mères grâce à des technologies basées sur l'IA
pour améliorer l'intégrité des signaux et maintenir des performances optimales sur les cartes mères multicouches. De plus, HyperTune BIOS, la technologie d'optimisation BIOS de GIGABYTE basée sur l'IA, ajuste intelligemment le comportement de la mémoire pour atteindre une vitesse d'horloge mémoire significative
More news about: GIGABYTE
Jun 07, 2026, 23:00 ET GIGABYTE nâng tầm hiệu năng bo mạch chủ với các công nghệ ứng dụng AI
mạch chủ nhằm nâng cao độ toàn vẹn tín hiệu và duy trì hiệu năng tối đa trên các cấu trúc bo mạch chủ nhiều lớp. Bên cạnh đó, HyperTune BIOS, công nghệ tối ưu hóa BIOS ứng dụng AI của GIGABYTE, có khả năng tinh chỉnh thông minh hành vi của bộ nhớ để đạt tốc độ xung nhịp bộ nhớ cao hơn và nâng cao hiệu
More news about: GIGABYTE
Jun 07, 2026, 23:00 ET 기가바이트, AI 기반 기술로 메인보드 성능 향상
AI 기술의 부상과 함께 기가바이트는 AI 기반 튜닝, 하드웨어 설계, 첨단 BIOS 최적화를 통합해 더 스마트하고 빠르며 다양한 환경에도 유연하게 대응하는 메인보드 플랫폼을 구현하고 있다. 기가바이트의 AI 강화 혁신의 핵심에는 동적 AI 오버클러킹 엔진과 전용 온보드 하드웨어 칩을 통해 AMD Ryzen™ X3D 프로세서 성능을 극대화하도록 설계된
More news about: GIGABYTE
Jun 05, 2026, 10:19 ET COMPUTEX 2026: MiTAC desenvolve infraestrutura de IA diversificada por meio de parcerias estratégicas de ecossistema
altamente flexível. A pilha de firmware de gerenciamento de placa-base de código aberto da MiTAC, MiOBMC™, juntamente com seu firmware de sistema (BIOS), MiOPF™, oferece aos operadores de data centers controle total sobre o hardware. A solução atende a requisitos rigorosos de personalização, ao
More news about: MiTAC Computing Technology Corp.
Jun 05, 2026, 10:13 ET COMPUTEX 2026: MiTAC impulsa una infraestructura diversificada de IA mediante asociaciones estratégicas del ecosistema
ágil, segura y muy flexible. La pila de firmware de gestión de placa base de código abierto de MiTAC, MiOBMC™, junto con su firmware de sistema (BIOS), MiOPF™, otorga a los operadores de centros de datos un control total del sistema sin software intermedio (bare-metal). Al liberar a los operadores
More news about: MiTAC Computing Technology Corp.
Jun 05, 2026, 01:55 ET Computex 2026 : MiTAC fait progresser une infrastructure d'IA diversifiée grâce à des partenariats stratégiques avec les écosystèmes
sécurisée et très flexible. La pile de micrologiciels de gestion des plinthes open source de MiTAC, MiOBMC™ et son micrologiciel de système (BIOS), MiOPF™, offrent aux opérateurs de centre de données un contrôle complet du métal nu. En libérant les opérateurs de l'immobilisation des fournisseurs,
More news about: MiTAC Computing Technology Corp.
Jun 04, 2026, 16:28 ET COMPUTEX 2026: MiTAC treibt den Ausbau einer breit gefächerten KI-Infrastruktur durch strategische Partnerschaften im Ökosystem voran
hochflexiblen Verwaltungsarchitektur gesteuert. MiTACs Open-Source-Baseboard-Management-Firmware-Stack MiOBMC™ in Verbindung mit der System-Firmware (BIOS) MiOPF™ gewährt Rechenzentrumsbetreibern vollständige Bare-Metal-Kontrolle. Indem er Betreiber von der Bindung an einen bestimmten Anbieter befreit,
More news about: MiTAC Computing Technology Corp.
Jun 04, 2026, 08:01 ET ARTAN Bio Raises $200,000 in Decentralized Funding to Advance Longevity Science Through Mutation-Specific Codon Suppression
company based in St. Petersburg, Florida, today announced the completion of a $200,000 seed raise. The raise will fund preclinical advancement of ARTAN Bio's proprietary engineered suppressor platform, which targets nonsense mutations — a class of genetic errors responsible for premature protein translation
More news about: ARTAN BIO